CLASS III Drug recall · Reported 20 Mar 2013 · FDA Enforcement Report

Calcium Gluconate Injection, USP, 10% (100 mg/mL), Single Dose Vial recalled

Fresenius Kabi USA LLC (FK USA) is recalling Calcium Gluconate Injection, USP, 10% (100 mg/mL), Single Dose Vial, distributed nationwide in the US. The recall was initiated on 1 Feb 2013 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot 6004889, Expiration Date 10/2014
Quantity recalled155,900 vials domestically

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-200-2013
FDA event ID
64266
Recalling firm
Fresenius Kabi USA LLC (FK USA), Schaumburg, IL
Classification
Class III
Status
Terminated
Recall initiated
1 Feb 2013
FDA classified
13 Mar 2013
Reported
20 Mar 2013
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Labeling Errors

Timeline

1 Feb 2013Recall initiated by company
13 Mar 2013Classified by FDA+40 days
20 Mar 2013Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: Missing label

Product as listed by the FDA

CALCIUM GLUCONATE INJECTION, USP, 10% (100 mg/mL), 10 mL, Single Dose Vial, Rx only, For Direct Slow IV or IV Additive Use Only, APP Pharmaceuticals, LLC Schaumburg, IL 60173 --- Product Code 31110, NDC 63323-311-10

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Labeling: Missing label

Which lots are affected?

Lot 6004889, Expiration Date 10/2014

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Fresenius Kabi USA LLC (FK USA)

All 2
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIIrinotecan Hydrochloride Injection, 40 mg recalledFresenius Kabi USA LLC (FK USA)OtherNationwide

Other Calcium Gluconate recalls

All 8